Literature DB >> 27272966

Risk Factors for Cerebral Venous Thrombosis.

Suzanne M Silvis1, Saskia Middeldorp2, Susanna M Zuurbier1, Suzanne C Cannegieter3, Jonathan M Coutinho1.   

Abstract

Cerebral venous thrombosis (CVT) is a rare thrombotic disorder involving the cerebral veins and dural sinuses. In contrast to more common sites of venous thromboembolism (VTE), such as the legs and lungs, CVT mainly affects young adults and children, and women are affected three times more often than men. Although presenting symptoms are variable, headache is usually the first symptom, often in combination with focal neurologic deficits and epileptic seizures. The primary therapy for CVT consists of heparin followed by oral anticoagulation for at least 3 to 6 months. The mortality in the acute phase is 5 to 10% and a substantial proportion of survivors suffer from long-term disabilities. A large number of risk factors have been linked to CVT, although the scientific evidence for an association varies considerably between risk factors. Some risk factors, such as hereditary thrombophilia, correspond with risk factors for more common sites of VTE, whereas others, such as head trauma, are specific to CVT. In most patients, at least one risk factor can be identified. In this review, we provide an overview of the risk factors for CVT. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27272966     DOI: 10.1055/s-0036-1584132

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  14 in total

1.  Elevated factor VIII increases the risk of cerebral venous thrombosis: a case-control study.

Authors:  Loes Vecht; Susanna M Zuurbier; Joost C M Meijers; Jonathan M Coutinho
Journal:  J Neurol       Date:  2018-05-08       Impact factor: 4.849

2.  Anticoagulation therapy in animal research.

Authors:  Victoria Hampshire
Journal:  Lab Anim (NY)       Date:  2016-10-20       Impact factor: 12.625

3.  Genome-Wide Association Study Identifies First Locus Associated with Susceptibility to Cerebral Venous Thrombosis.

Authors:  Gie Ken-Dror; Ioana Cotlarciuc; Ida Martinelli; Elvira Grandone; Sini Hiltunen; Erik Lindgren; Maurizio Margaglione; Veronique Le Cam Duchez; Aude Bagan Triquenot; Marialuisa Zedde; Michelangelo Mancuso; Ynte M Ruigrok; Thomas Marjot; Brad Worrall; Jennifer J Majersik; Tiina M Metso; Jukka Putaala; Elena Haapaniemi; Susanna M Zuurbier; Matthijs C Brouwer; Serena M Passamonti; Maria Abbattista; Paolo Bucciarelli; Braxton D Mitchell; Steven J Kittner; Robin Lemmens; Christina Jern; Emanuela Pappalardo; Paolo Costa; Marina Colombi; Diana Aguiar de Sousa; Sofia Rodrigues; Patrícia Canhão; Aleksander Tkach; Rosa Santacroce; Giovanni Favuzzi; Antonio Arauz; Donatella Colaizzo; Kostas Spengos; Amanda Hodge; Reina Ditta; Alessandro Pezzini; Stephanie Debette; Jonathan M Coutinho; Vincent Thijs; Katarina Jood; Guillaume Pare; Turgut Tatlisumak; José M Ferro; Pankaj Sharma
Journal:  Ann Neurol       Date:  2021-09-29       Impact factor: 10.422

4.  Misdiagnosis of Cerebral Vein Thrombosis in the Emergency Department.

Authors:  Ava L Liberman; Gino Gialdini; Ekaterina Bakradze; Abhinaba Chatterjee; Hooman Kamel; Alexander E Merkler
Journal:  Stroke       Date:  2018-04-25       Impact factor: 7.914

5.  Suspected adverse reaction to compounded preparations prescribed for weight loss: two cases of cerebral venous thrombosis.

Authors:  Beatrice Mainoli; Mariana Carvalho Dias; Patricia Canhão; Mário Miguel Rosa
Journal:  BMJ Case Rep       Date:  2020-03-31

6.  Relationship between thrombomodulin gene polymorphism and susceptibility to venous thromboembolism: A protocol for systematic review and meta-analysis.

Authors:  Meihao Wei; Xiaohui Xue; Yipeng Pan; Yan Wu
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

7.  Cerebral venous thrombosis of the sphenoparietal sinus: A case report.

Authors:  Camille K Milton; David L Gordon; Chad A Glenn; Andrew K Conner
Journal:  Surg Neurol Int       Date:  2021-05-03

8.  Tofacitinib-Associated Cerebral Venous Sinus Thrombosis.

Authors:  Zakaria Hakma; Natalie Gofman; Danielle Brown; Ethan Fitzgerald
Journal:  ACG Case Rep J       Date:  2021-07-20

9.  Reversible cerebral vasoconstriction syndrome concomitant with cerebral venous sinus thrombosis following ovarian tumor resection: A report of two cases.

Authors:  Yu Shimizu; Katsuhiro Tsuchiya; Hironori Fujisawa
Journal:  Surg Neurol Int       Date:  2020-05-30

10.  CVT in the Peripartum Period: A Diagnostic Dilemma.

Authors:  Leah Allbright; Francine McLeod; Donald Mauney
Journal:  Case Rep Obstet Gynecol       Date:  2020-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.